Exhibit 99.03













Volition RX Limited

(A Development Stage Company)


Pro-Forma Financial Statements


For the Period Ended June 30, 2011


(unaudited – prepared by management)




















Pro-Forma Balance Sheets

2

Pro-Forma Statements of Operations for the period ended September 30, 2011

3

Pro-Forma Statements of Operations for the year ended December 31, 2010

4

Notes to the Pro-Forma Financial Statements

5







Volition RX Limited

(A Development Stage Company)

Pro-Forma Balance Sheets

As at June 30, 2011

(Expressed in US dollars)

(unaudited)


 

 

 Standard Capital as at May 31,

 2011

 $

 Singapore Volition as at June 30,

 2011

 $

Pro-Forma Adjustments

$

Pro-Forma Consolidated

$

 

 

 

(Note 3)

 

ASSETS

 

 

 

 

 

 

 

 

 

Cash

1,060

272,393

–

273,453

Refundable deposits

–

5,700

–

5,700

Other current assets

–

27,500

–

27,500

 

 

 

 

 

Total Current Assets

1,060

305,593

–

306,653

 

 

 

 

 

Property and equipment

–

5,470

–

5,470

Intangible assets

–

1,704,204

 

1,704,204

 

 

 

 

 

Total Assets

1,060

2,015,267

–

2,016,327

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

54,273

132,941

–

187,214

Accrued officers’ salaries

–

34,000

–

34,000

Due to related parties

70,782

58,156

–

128,938

Notes payable

–

1,376,632

–

1,376,632

 

 

 

 

 

Total Current Liabilities

125,055

1,601,729

–

1,726,784

 

 

 

 

 

Grant payable

–

694,707

–

694,707

 

 

 

 

 

Total Liabilities

125,055

2,296,436

–

2,421,491

 

 

 

 

 

STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

 

Preferred stock

–

–

–

–

 

 

 

 

 

Common stock

2,285

1,356,670

(1,348,549)

8,121

 

 

 

(1,212)

 

 

 

 

(1,073)

 

 

 

 

 

 

Additional paid-in capital

100,665

131,562

1,348,549

1,480,111

 

 

 

(101,738)

 

 

 

 

1,073

 

 

 

 

 

 

Share subscriptions received

–

65,907

–

65,907

 

 

 

 

 

Other comprehensive income

–

18,574

–

18,574

 

 

 

 

 

Accumulated deficit during the development stage

(226,945)

(1,853,882)

(123,995)

(1,977,877)

 

 

 

226,945

 

 

 

 

 

 

Total Stockholders’ Equity (Deficit)

(123,995)

(281,169)

–

(405,164)

 

 

 

 

 

Total Liabilities and Stockholders’ Equity (Deficit)

1,060

2,015,267

–

2,016,327

 

 

 

 

 




2





Volition RX Limited

(A Development Stage Company)

Pro-Forma Statement of Operations

For the Period Ended May 31 and June 30, 2011

(Expressed in US dollars)

(unaudited)


 

Standard Capital

for the nine

months ended

May 31,

2011

$

Singapore

Volition for the

six months

ended

June 30,

2011

$

Pro-Forma

Adjustments

$

Pro-Forma

Consolidated

$

 





Revenues

–

–

–

–

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

Depreciation and amortization

–

47,433

–

47,433

General and administrative

1,808

208,272

–

210,080

Professional fees

7,900

68,453

–

76,353

Research and development

–

268,745

–

268,745

Salaries and office administrative fees

–

366,859

–

366,859

 

 

 

 

 

Total Operating Expenses

9,708

959,762

–

969,470

 

 

 

 

 

Net Loss

(9,708)

(959,762)

–

(969,470)


Pro Forma Loss Per Share (Note 5)        

 

 

 

 

 

 

 

 

 




3





Volition RX Limited

(A Development Stage Company)

Pro-Forma Statement of Operations

For the Year Ended August 31 and December 31, 2010

(Expressed in US dollars)

(unaudited)


 

Standard Capital for the year ended August 31,

2010

$

Singapore Volition for the period from August 5, 2010 (date of inception) to December 31,

2010

$

Pro-Forma Adjustments

$

Pro-Forma Consolidated

$

 





Revenues

–

–

–

–

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

Depreciation and amortization

–

21,101

–

21,101

General and administrative

10,947

43,126

–

54,073

Professional fees

–

624,801

–

624,801

Research and development

–

60,871

–

60,871

Salaries and office administrative fees

–

144,221

–

144,221

 

 

 

 

 

Total Operating Expenses

10,947

894,120

–

905,067

 

 

 

 

 

Net Loss

(10,947)

(894,120)

–

(905,067)


Pro Forma Loss Per Share (Note 5)        

 

 

 

 

 

 

 

 

 




4



Volition RX Limited

(A Development Stage Company)

Notes to the Pro-Forma Financial Statements

(Expressed in US dollars)

(unaudited)


1.

Basis of Presentation


On September 26, 2011, Standard Capital Corporation (“SCC” or the “Company”) entered into a share exchange agreement with Singapore Volition Pte Ltd. (“Singapore”), a private corporation formed under the republic of Singapore.  Under the terms of the agreement, SCC will acquire 100% of the issued and outstanding common shares of Singapore in exchange for 6,908,652 common shares of the Company.  After the close of the share exchange agreement, the former shareholders of Singapore will control approximately 85% of the total issued and outstanding common shares of SCC, resulting in a reverse takeover.  The share exchange agreement closed on October 6, 2011 and the Company was renamed “Volition RX Limited”.


These unaudited pro forma financial statements (“pro forma financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in US dollars.  These pro forma financial statements do not contain all of the information required for annual financial statements. Accordingly, they should be read in conjunction with the most recent annual and interim financial statements of SCC.


These pro forma financial statements have been compiled from and include:


(a) an unaudited pro forma balance sheet combining the unaudited interim balance sheet of SCC as at May 31, 2011 and Singapore as at June 30, 2011, giving effect to the transaction as if it occurred on October 6, 2011;


(b) an unaudited pro forma statement of operations combining the unaudited interim statement of operations of SCC for the nine months ended May 31, 2011 and Singapore for the six months ended June 30, 2011; and  


(c) an unaudited pro forma statement of operations combining the audited statement of operations of SCC for the year ended August 31, 2010 and Singapore for the period from August 5, 2010 (date of inception) to December 31, 2010.


The unaudited pro forma financial statements have been compiled using the significant accounting policies as set out in the audited financial statements of the Company for the year ended August 31, 2010. Based on the review of the accounting policies of SCC and Singapore, there are no material accounting differences between the accounting policies of the companies. The unaudited pro forma financial statements should be read in conjunction with the historical financial statements and notes thereto of Singapore.


It is management’s opinion that these pro forma financial statements include all adjustments necessary for the fair presentation, in all material respects, of the proposed transaction described above in accordance with US GAAP applied on a basis consistent with SCC’s accounting policies. No adjustments have been made to reflect potential cost savings that may occur subsequent to completion of the transaction. The pro forma statement of operations does not reflect non-recurring charges or credits directly attributable to the transaction, of which none are currently anticipated.


The unaudited pro forma financial statements are not intended to reflect the results of operations or the financial position of Volition RX Limited which would have actually resulted had the proposed transaction been effected on the dates indicated. Further, the unaudited pro forma financial information is not necessarily indicative of the results of operations that may be obtained in the future. The pro forma adjustments and allocations of the purchase price for SCC are based in part on provisional estimates of the fair value of the assets acquired and liabilities assumed. Any final adjustments may change the allocation of purchase price which could affect the fair value assigned to the assets and liabilities and could result in a change to the unaudited pro forma consolidated financial statements.




5



Volition RX Limited

(A Development Stage Company)

Notes to the Pro-Forma Financial Statements

(Expressed in US dollars)

(unaudited)


2.

Business Acquisition


On September 26, 2011, the Company entered into a share exchange agreement with Singapore and the shareholders of all of the issued and outstanding common shares of Singapore.  The share exchange agreement closed on October 6, 2011.    


Pursuant to the agreement, SCC acquired all of the outstanding shares of common stock of Singapore (6,908,652 common shares) by issuing 6,908,652 common shares  As a result of the share exchange, the former shareholders of Singapore will control approximately 85% of the issued and outstanding common shares of SCC.  The transaction was accounted for as a reverse takeover using the acquisition method with Singapore being treated as the acquirer pursuant to Accounting Standards Codification (“ASC”) 805-40, Business Combinations – Reverse Acquisitions. Accordingly, because Singapore is deemed to be the purchaser for accounting purposes, these pro forma financial statements are presented as a continuation of Singapore.  As a result, no goodwill or intangible asset was recorded.  The reverse takeover transaction was treated as the issuance of equity by Singapore for the acquisition of SCC’s net assets.


The preliminary allocation of the purchase price is summarized in the table below and is subject to change.


 

$

Fair value of SCC’s net assets to be acquired

 

 

 

Cash

1,060

Accounts payable and accrued liabilities

(54,273)

Due to related parties

(70,782)

 

 

Net liabilities assumed on acquisition

(123,995)


3.

Pro Forma Assumptions and Adjustments


The unaudited pro-forma consolidated financial statements incorporate the following pro forma assumptions and adjustments:


(a)

For purposes of these pro-forma consolidated financial statements, it is assumed that all shareholders of Singapore exchanged their common shares for 6,908,652 common shares of SCC, at a rate of one common share of SCC for each Singapore common share.  The excess purchase consideration over the fair value of Singapore’s assets and liabilities has been charged to deficit on a pro-forma basis, as described in Note 2.  


(b)

Prior to the acquisition on October 6, 2011, SCC returned to treasury and cancelled 1,073,000 issued and outstanding common shares.


4.

Pro-Forma Common Shares


Pro-forma common shares as at June 30, 2011, have been determined as follows:


 

Number of

Common Shares

Par

Value

$

Additional

Paid-in

Capital

$

 

 

 

 

Issued and outstanding common shares of SCC

2,285,000

2,285

100,665

Issued and outstanding common shares of Singapore

5,211,341

1,356,670

131,562

Cancellation of issued and outstanding common shares of SCC

(1,073,000)

(1,073)

1,073

Eliminate issued and outstanding common shares of Singapore, and adjust to reflect par value

(5,211,341)

(1,356,670)

–

Issuance of common shares for acquisition

6,908,652

6,909

1,246,811

 

 

 

 

Pro-forma balance

8,120,652

8,121

1,480,111




6



Volition RX Limited

(A Development Stage Company)

Notes to the Pro-Forma Financial Statements

(Expressed in US dollars)

(unaudited)



5.

Pro-Forma Loss Per Share


Pro-forma basic and diluted loss per share for the period ended June 30, 2011 and year ended December 31, 2010 have been calculated based on the weighted average number of SCC common shares outstanding plus the common shares issued for the acquisition of Singapore.


 

Period ended June 30,

2011

Year Ended

December 31,

2010

 

 

 

Basic pro forma loss per share computation

 

 

 

 

 

Numerator:

 

 

Pro forma net loss available to stockholders

$ (969,470)

$ (905,067)

 

 

 

Denominator:

 

 

Issued and outstanding common shares of SCC

1,212,000

1,212,000

Common shares issued for acquisition of Singapore

6,908,652

6,908,652

Pro forma weighted average shares outstanding

8,120,652

8,120,652

 

 

 

Basic and Diluted pro forma loss per share

(0.12)

(0.11)




7